Gynecologic Cancer News

An HPV vaccination intervention that was implemented in schools modestly improved psychosocial vaccine-related outcomes like decision-making in adolescents, according to findings published in JAMA Network Open.

Increased use of neoadjuvant chemotherapy appeared associated with improvements in short-term mortality without sacrificing long-term survival in ovarian cancer, according to a comparative effectiveness research study in JAMA Oncology.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

A considerable proportion of women who never received an HPV vaccine also never underwent cervical cancer screening or were not up to date on screening in 2019, according to findings published in JAMA Network Open.

The FDA granted fast track designation to nemvaleukin alfa as part of combination therapy for treatment of platinum-resistant ovarian cancer, according to the agent’s manufacturer.

A personalized approach to radiation therapy can maximize therapeutic effect across multiple cancer types, according to findings published in The Lancet Oncology.

Although cervical cancer elimination appears to be within reach in the United States, a predictive model anticipated an approximately decade-long gap between low-poverty and high-poverty areas of the country in achieving this goal.

Use of personalized interventions significantly reduced grade 3 or higher chemotherapy-related toxicity among patients with cancer aged 65 years or older, randomized trial results showed.

In a study of patients with endometrial stromal sarcomas treated with aromatase inhibitors the objective response rate was more modest than expected, but a majority did achieve stable disease, according to a study presented at the ASCO Annual Meeting.

New data have linked next-generation sequencing with improved overall survival in ovarian cancer, according to a presenter at the virtual ASCO Annual Meeting.